Novocure Ltd (NVCR)

[jondoeuk]

You played with the numbers the wrong way.

What?

Dr. Stupp's expertise is in the domain of chemo which will be made obsolete by DCVax-L sooner than expected.

Again, Prof. Stupp, is an internationally renowned medical oncologist and neuro-oncologist, and a leading authority on primary and metastatic brain cancers. He was one of many experts who have written about NWBO's trial. Also, patients were randomised to either SOC (adjuvant chemo) plus placebo or SOC plus -L.

Take a look at the type of research he is doing. Will any GBM patients try the treatment he was researching if DCVax-L is available?

Those given a placebo had a better PFS, as well as OS, which means -L failed.